Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas
Author
Ng, Alvin Wei TianContino, Gianmarco
Killcoyne, Sarah
Devonshire, Ginny
Hsu, Ray
Abbas, Sujath
Su, Jing
Redmond, Aisling M
Weaver, Jamie M J
Eldridge, Matthew D
Tavaré, Simon
Edwards, Paul A W
Fitzgerald, Rebecca C
Affiliation
University of Cambridge; University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; European Bioinformatics Institute EMBL-EBI; The Christie NHS Foundation Trust; Columbia UniversityPublication date
2022-04-08
Metadata
Show full item recordAbstract
Oesophageal adenocarcinoma (OAC) provides an ideal case study to characterize large-scale rearrangements. Using whole genome short-read sequencing of 383 cases, for which 214 had matched whole transcriptomes, we observed structural variations (SV) with a predominance of deletions, tandem duplications and inter-chromosome junctions that could be identified as LINE-1 mobile element (ME) insertions. Complex clusters of rearrangements resembling breakage-fusion-bridge cycles or extrachromosomal circular DNA accounted for 22% of complex SVs affecting known oncogenes. Counting SV events affecting known driver genes substantially increased the recurrence rates of these drivers. After excluding fragile sites, we identified 51 candidate new drivers in genomic regions disrupted by SVs, including ETV5, KAT6B and CLTC. RUNX1 was the most recurrently altered gene (24%), with many deletions inactivating the RUNT domain but preserved the reading frame, suggesting an altered protein product. These findings underscore the importance of identification of SV events in OAC with implications for targeted therapies.Citation
Ng AWT, Contino G, Killcoyne S, Devonshire G, Hsu R, Abbas S, Su J, Redmond AM, Weaver JMJ, Eldridge MD, Tavaré S; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium; Edwards PAW, Fitzgerald RC. Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas. Commun Biol. 2022 Apr 8;5(1):335. doi: 10.1038/s42003-022-03238-7.Type
ArticleAdditional Links
https://www.nature.com/commsbio/PMID
35396535Journal
Communications BiologyPublisher
Nature Publishing Groupae974a485f413a2113503eed53cd6c53
10.1038/s42003-022-03238-7